Why carry out this study?

Low-level light therapy (LLLT) is an emerging promising option for the treatment of dry eye disease (DED) owing to meibomian gland dysfunction (MGD)

Previous studies have demonstrated the efficacy on patients’ signs and symptoms of in-office LLLT mask used alone or in combination with intense pulsed light in the setting of DED owing to MGD

What was learned from the study?

A weekly protocol of serial sessions with a newly developed LLLT mask for home use allowed the significant improvement of both tear production and stability along with the significant amelioration of ocular discomfort symptoms

These results open up a new scenario for patients with MGD who can enjoy the unique benefits of LLLT technology at home